Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Light chain myeloma pts have elevated creatinine (>2), beta-2 ≥5.5, elevated LDH, hypercalcemia, t(11;14), del(13q) and t(6;14); IMS-IMWG high-risk, hyperdiploidy, t(4;14), serum albumin <3.5 are less common; PFS and OS same.”
Title: Clinical Characteristics, Treatment Responses, and Outcomes of Light Chain Multiple Myeloma
Authors: Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, Francis K. Buadi, Suzanne R. Hayman, Morie A. Gertz, Angela Dispenzieri, Eli Muchtar, Prashant Kapoor, Wilson Gonsalves, Taxiarchis Kourelis, David Dingli, Rahma Warsame, Nelson Leung, Joselle Cook, Moritz Binder, Yi Lin, Yi Hwa, Michelle G. Rogers, Miriam Hobbs, Amie Fonder, Dragan Jevremovic, S. Vincent Rajkumar, Shaji K. Kumar
You can read the Full Article in the American Journal of Hematology.
You can find more posts featuring Robert Orlowski on OncoDaily.
